{"schema_version":"secwatch.filing_event.v1","accession":"0001124140-25-000003","form_type":"8-K","ticker":null,"cik":"0001124140","company_name":"EXACT SCIENCES CORP","filed_at":"2025-01-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:02.980856+00:00","generated_at":"2026-05-28T09:47:58.814615+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Exact Sciences appoints Kim Popovits to Board of Directors","bullets":["Board expanded from 9 to 10 members; Popovits appointed Class I director, term ends at 2025 annual meeting.","Popovits previously served as President and CEO of Genomic Health until Exact Sciences' 2019 acquisition.","She brings over 40 years healthcare experience, including leadership roles at Genentech and Genomic Health.","Received initial stock award valued at $375,000 per non-employee director compensation policy.","Currently serves on boards of Kiniksa Pharmaceuticals, 10x Genomics, and Talis Biomedical."],"urls":{"canonical":"https://secwatch.observer/filing/0001124140-25-000003","json":"https://secwatch.observer/filing/0001124140-25-000003.json","markdown":"https://secwatch.observer/filing/0001124140-25-000003.md","text":"https://secwatch.observer/filing/0001124140-25-000003.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1124140/000112414025000003/0001124140-25-000003-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1124140/000112414025000003/exas-20250102.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T09:47:58.814615+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"066e17766c","claim":"Kim Popovits was appointed as Class I member of the Board at EXACT SCIENCES CORP.","evidence_excerpt":"On January 2, 2025, the Board of Directors (the “Board”) of Exact Sciences Corporation (the “Company”) expanded the size of the Board from nine to ten members and appointed Kim Popovits as a Class I member of the Board with a term ending at the Company’s 2025 annual meeting of shareholders.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1124140/000112414025000003/0001124140-25-000003-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Class I member of the Board"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}